Tomorrow....Anyone who sells on these financials isn't right. Couldn't ask for a better quarter. Love the way this company is being managed. Too many positive catalysts to look forward to in H2 2019. Revenues are only going to increase over the coming quarters/years. They've already figured out how to operate profitably. Margins will only get better. Today's financials really validated MediPharm as a strong buy and long term hold. Predicting we see a double digit gain day tomorrow and new all-time highs. Today's sellers will be scrambling to jump back in.